The FASEB Journal, Vol 11, 973-980, Copyright © 1997 by The Federation of American Societies for Experimental Biology

RESEARCH COMMUNICATIONS

Epinephrine enhances glycogen turnover and depresses glucose uptake in vivo in rat heart

MT Huang, CF Lee and GP Dobson
Department of Biochemistry, Chang Gung College of Medicine and Technology, Tao-yuan, Taiwan.

In vivo effects of epinephrine on glucose uptake and glycogen turnover in rat heart were studied and compared to liver and skeletal muscle. Fasted ketamine-anesthetized rats were intravenously infused with saline or epinephrine. Both the low and high doses of epinephrine resulted in hyperglycemia (40-50%) and hyperlactemia (threefold) at the end of infusion. Glucose uptake, determined by the phosphorylation of the intravenously injected [14C]2-deoxyglucose, was found to decrease in the heart and skeletal muscle of epinephrine-infused rats. Glycogen in livers, skeletal muscles, and hearts of the epinephrine-infused rats decreased to varying degrees relative to the saline-infused rats, indicating enhanced glycogenolysis in all three organs. Glycogen synthesis, determined by the incorporation of the co-infused [3- (3)H]glucose into glycogen, was found to decrease in liver and skeletal muscle. However, glycogen synthesis in the heart was found to increase 50% in Epi-1 and 280% in Epi-2 compared to the saline-infused rats. We conclude that glucose utilization in the in vivo heart may be preferentially channeled through glycogen turnover in the presence of epinephrine. That both synthesis and degradation of glycogen can be simultaneously activated appears to be unique to the heart and is protective against a loss of glycogen at a time of enhanced glucose utilization.

This article has been cited by other articles:

				T. Yoshida, T. Hibino, N. Kako, S. Murai, M. Oguri, K. Kato, K. Yajima, N. Ohte, K. Yokoi, and G. Kimura A pathophysiological study of tako-tsubo cardiomyopathy with F-18 fluorodeoxyglucose positron emission tomography: reply Eur. Heart J., March 1, 2008; 29(5): 681 - 682. [Full Text] [PDF]

				T. Yoshida, T. Hibino, N. Kako, S. Murai, M. Oguri, K. Kato, K. Yajima, N. Ohte, K. Yokoi, and G. Kimura A pathophysiologic study of tako-tsubo cardiomyopathy with F-18 fluorodeoxyglucose positron emission tomography Eur. Heart J., November 1, 2007; 28(21): 2598 - 2604. [Abstract] [Full Text] [PDF]

				P. T. Fueger, D. P. Bracy, C. M. Malabanan, R. R. Pencek, and D. H. Wasserman Distributed control of glucose uptake by working muscles of conscious mice: roles of transport and phosphorylation Am J Physiol Endocrinol Metab, January 1, 2004; 286(1): E77 - E84. [Abstract] [Full Text]

				T. R. Wallhaus, M. Taylor, T. R. DeGrado, D. C. Russell, P. Stanko, R. J. Nickles, and C. K. Stone Myocardial Free Fatty Acid and Glucose Use After Carvedilol Treatment in Patients With Congestive Heart Failure Circulation, May 22, 2001; 103(20): 2441 - 2446. [Abstract] [Full Text] [PDF]

				S. Egert, N. Nguyen, and M. Schwaiger Contribution of {alpha}-Adrenergic and ß-Adrenergic Stimulation to Ischemia-Induced Glucose Transporter (GLUT) 4 and GLUT1 Translocation in the Isolated Perfused Rat Heart Circ. Res., June 25, 1999; 84(12): 1407 - 1415. [Abstract] [Full Text]

				T. Doenst and H. Taegtmeyer {alpha}-Adrenergic Stimulation Mediates Glucose Uptake Through Phosphatidylinositol 3-Kinase in Rat Heart Circ. Res., March 5, 1999; 84(4): 467 - 474. [Abstract] [Full Text]